(Q46427553)

22 December 2017

title

Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling? (English)

1 reference

22 December 2017

author

Hans-Christoph Diener

series ordinal

1

object named as

Hans-Christoph Diener

1 reference

22 December 2017

publication date

1 February 2006

1 reference

22 December 2017

International Journal of Stroke

published in

1 reference

22 December 2017

volume

1

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

4-8

1 reference

22 December 2017

Vascular event rates in patients with atherosclerotic cerebrovascular disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Etiology, duration, and prognosis of transient ischemic attacks: an analysis from the German Stroke Data Bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Timing of TIAs preceding stroke: time window for prevention is very short

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Short-term prognosis after emergency department diagnosis of TIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Controlled Trial of Dipyridamole in Cerebral Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

Clopidogrel for the secondary prevention of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1747-4949.2005.00016.X

10.1111/J.1747-4949.2005.00016.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017